NEW YORK ( TheStreet) -- CHANGE IN RATINGS:Aaron's ( AAN) downgraded at Canaccord from buy to hold, Canaccord Genuity said. $30 price target. Rent-to-own industry remains under pressure. AbbVie ( ABBV) rated new neutral at Credit Suisse. $37 price target. Cross currents imply minimal stock movement from current price. Akamai Tech ( AKAM) downgraded at Jefferies to hold from buy, Jefferies said. $40 price target. Reinvestments tough on short- term outlook. Compass Minerals International ( CMP) upgraded to buy at TheStreet Ratings. Conceptus ( CPTS) upgraded to buy at TheStreet Ratings. Con-Way ( CNW) upgraded at Citigroup to buy from neutral, Citigroup said. $39 price target. Incremental margin and cost analysis suggests upside to 1H13 EPS. DeVry ( DV) upgraded at JP Morgan from underweight to neutral, JP Morgan said. Company is seeing higher enrollment rates. Fortune Brands Home & Security ( FBHS) upgraded at KeyBanc to buy from hold, KeyBanc said. $38 price target. Company outgrows peers on the basis of its attractive market positions. Google ( GOOG) downgraded at Pivotal from buy to hold, Pivotal Research said. Valuation call, based on an $820 price target. Google rated new neutral at Sterne Agee. Company mays struggle to monetize its mobile business. Johnson & Johnson ( JNJ) downgraded at Credit Suisse from neutral to underperform, Credit Suisse said. Valuation call, based on a $73 price target. Life Time Fitness ( LTM) upgraded at Stifel from hold to buy, Stifel Nicolaus said. $50 price target. Stock appears oversold at current levels. Molycorp ( MCP) upgraded at JP Morgan from underweight to neutral, JP Morgan said. $6 price target. Capital raise removes near-term risks. Owens Corning ( OC) downgraded at KeyBanc to hold from buy, KeyBanc said. High growth expectations and past margin volatility. PACCAR ( PCAR) downgraded at UBS to neutral from buy, UBS said. $48 price target. Valuation call. Pfizer ( PFE) downgraded at Credit Suisse from Outperform to neutral, Credit Suisse said. New analyst has a $29 price target. Reliance Steel ( RS) upgraded at Dahlman from hold to buy, Dahlman Rose said. $89 price target. MUSA deal should add to earnings. Stryker ( SYK) downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. Valuation call, based on a $67 price target.
STOCK COMMENTS / EPS CHANGESAllergan ( AGN) price target increased at Citigroup to $124, Citigroup said. Core franchises continue to deliver double digit growth. Buy rating. Akamai Tech ( AKAM) target lowered at Jefferies. Shares of AKAM now seen reaching $48, Oppenheimer said. Weak quarterly report. Outperform rating. Biogen Idec ( BIIB) numbers raised at Jefferies. Shares of BIIB now seen reaching $210, Jefferies said. Estimates also raised on acquisition of Tysabri rights. Buy rating. Cummins ( CMI) target raised at UBS to $135, UBS said. Opportunity to rally as investors were braced for cautious guidance. Cummins target lowered at Jefferies to $110, Jefferies said. Solid quarter and guidance. Hold rating. CVS Caremark ( CVS) numbers increased at Guggenheim. CVS estimates were raised through 2014, Guggenheim said. Company boosted its guidance. Buy rating and new $60 price target. Green Mountain ( GMCR) numbers boosted at Lazard. Shares of GMCR now seen reaching $58, according to Lazard Capital Markets. Estimates also upped, given a better margin outlook. W.R. Grace ( GRA) numbers raised at Jefferies. Shares of GRA now seen reaching $90, Jefferies said. Estimates also raised on solid earnings momentum. Buy rating. InterActiveCorp ( IACI) estimates, target cut at Credit Suisse. Shares of IACI now seen reaching $62, according to Credit Suisse. Estimates also reduced, given a deceleration of search growth. Outperform rating. Panera Bread ( PNRA) target raised at Jefferies to $190, Jefferies said. Trends are quite steady vs peers. Buy rating. Ralph Lauren ( RL) numbers raised at UBS. Shares of RL now seen reaching $195, UBS said. Estimates also increased on an accelerating top line story. Buy rating. Ralph Lauren numbers raised at Credit Suisse. Shares of RL now seen reaching $198, according to Credit Suisse. Estimates also increased, given higher international growth and margin expansion. Outperform rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.